Lymphoma of the Ocular Adnexa and Skin of Eyelid
Primary Site | Histology | Staging Type |
---|---|---|
C441, C690, C695-C696 | 9590-9699, 9702-9738, 9811-9818, 9820-9837 | TNM 7 and Summary Stage |
If you are working with a site/histology that only summary stages and you need to directly code it, please use the SEER Summary Stage 2000 manual
Notes
M-9590-9699,9702-9738, 9811-9818,9820-9837 C441 Skin of Eyelid C690 Conjunctiva C695 Lacrimal Gland C696 Orbit **Note 1:** This schema is based on the UICC chapters *Hodgkin & Non-Hodgkin Lymphomas,* pages 304-310. * UICC does not define Lymphoma Ocular Adnexa. A list of all possible values are provided for T, N and M (no definitions are available) * Assign Clinical and Pathologic Stage Group using the Lymphoma chapter **Note 2:** Laterality must be coded for this site. **Note 3:** In addition to directly assigning Clinical and Pathologic Stage Group, Summary Stage 2000 (SS2000) must be captured. If directly assigning SS2000, use the *Hodgkin & Non-Hodgkin Lymphoma of All Sites* chapter on page 284 of the [SS2000 on-line manual](https://seer.cancer.gov/tools/ssm/ssm2000/SSSM2000-122012.pdf#page=284).Main Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Clinical T | <BLANK> | No |
NAACCR #940
tnmClinT |
None | |
Clinical N | <BLANK> | No |
NAACCR #950
tnmClinN |
None | |
Clinical M | <BLANK> | No |
NAACCR #960
tnmClinM |
None | |
TNM Clin Stage Group | 99 | Yes |
NAACCR #970
tnmClinStageGroup |
None | |
Pathologic T | <BLANK> | No |
NAACCR #880
tnmPathT |
None | |
Pathologic N | <BLANK> | No |
NAACCR #890
tnmPathN |
None | |
Pathologic M | <BLANK> | No |
NAACCR #900
tnmPathM |
None | |
TNM Path Stage Group | 99 | Yes |
NAACCR #910
tnmPathStageGroup |
None | |
SSF1: Associated with HIV/AIDS | 999 | No |
NAACCR #2880
csSiteSpecificFactor1 |
CCCR/Canada COC SEER |
None |
SSF2: Systemic Symptoms at Diagnosis | 999 | Yes |
NAACCR #2890
csSiteSpecificFactor2 |
All | None |
SSF3: International Prognostic Index (IPI) | 988 | No |
NAACCR #2900
csSiteSpecificFactor3 |
CCCR/Canada COC |
None |
SSF4: Follicular Lymphoma Prognostic Index (FLIPI) | 988 | No |
NAACCR #2910
csSiteSpecificFactor4 |
None | None |
SSF5: Ki-67/MIB-1 Labeling Index (LI): Ophthalmic | 988 | No |
NAACCR #2920
csSiteSpecificFactor5 |
None | None |
SSF6: Lactate Dehydrogenase (LDH) | 988 | No |
NAACCR #2930
csSiteSpecificFactor6 |
CCCR/Canada COC |
None |
SSF7: Rheumatoid Arthritis | 988 | No |
NAACCR #2861
csSiteSpecificFactor7 |
None | None |
SSF8: Sjogren Syndrome | 988 | No |
NAACCR #2862
csSiteSpecificFactor8 |
None | None |
SSF9: Other Connective Tissue Disease | 988 | No |
NAACCR #2863
csSiteSpecificFactor9 |
None | None |
SSF10: Sicca Syndrome | 988 | No |
NAACCR #2864
csSiteSpecificFactor10 |
None | None |
Additional Data Items
Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
---|---|---|---|---|---|
Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | |
Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
None | |
Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
None |
Initial Context
Outputs
Name | Default Value | Description | NAACCR Item | Metadata |
---|---|---|---|---|
Derived Version | {{ctx_alg_version}} | None | None | |
Derived SEER Clin Stage Group | 88 |
NAACCR #3610
derivedSeerClinStgGrp |
None | |
Derived SEER Path Stage Group | 88 |
NAACCR #3605
derivedSeerPathStgGrp |
None | |
Derived SEER Combined Stage Group | 88 |
NAACCR #3614
derivedSeerCmbStgGrp |
None | |
Derived SEER Combined T | 88 |
NAACCR #3616
derivedSeerCombinedT |
None | |
Derived SEER Combined N | 88 |
NAACCR #3618
derivedSeerCombinedN |
None | |
Derived SEER Combined M | 88 |
NAACCR #3620
derivedSeerCombinedM |
None | |
Derived SEER Combined T Source | <BLANK> |
NAACCR #3622
derivedSeerCmbTSrc |
None | |
Derived SEER Combined N Source | <BLANK> |
NAACCR #3624
derivedSeerCmbNSrc |
None | |
Derived SEER Combined M Source | <BLANK> |
NAACCR #3626
derivedSeerCmbMSrc |
None |